Editorial: Continuous monitoring to improve outcome of treatment-the next step towards safe and effective faecal microbiota transplantation. Authors' reply

Aliment Pharmacol Ther. 2023 Nov;58(9):948-949. doi: 10.1111/apt.17721.

Authors

Simon Mark Dahl Baunwall^{1

2}, Mette Mejlby Hansen¹, Sara Ellegaard Andreasen^{1

2}, Marcel Kjaersgaard Eriksen¹, Nina Rågård¹, Jens Kelsen¹, Anne Karmisholt Grosen^{2

3}, Susan Mikkelsen³, Christian Erikstrup^{2

3}, Jens Frederik Dahlerup^{1

2}, Christian Lodberg Hvas^{1

2}

Affiliations

¹ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
² Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
³ Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.

PMID: 37831525
DOI: 10.1111/apt.17721

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clostridium Infections*
Fecal Microbiota Transplantation* / adverse effects
Feces
Humans
Treatment Outcome